Every EDGAR filing for Akari Therapeutics Plc (AKTX), newest first, with AI summaries and stories.
Next: earnings expected ~Oct 30 ยท 10-Q expected ~Nov 16 (deadline Nov 16)
No open-market insider buys in the last 30 days.
Also: 17 grants or exercises.
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
Abizer Gaslightwala, insider filing for AKTX
Abizer Gaslightwala, reporting
Vatnak Vat-Ho, insider filing for AKTX
Vatnak Vat-Ho, reporting
Abizer Gaslightwala, insider filing for AKTX
Abizer Gaslightwala
Kameel D. Farag, insider filing for AKTX
Kameel D. Farag, reporting
Ownership stake disclosure by BANK OF MONTREAL /CAN/
BANK OF MONTREAL /CAN/, filed by
Ownership stake disclosure by White Lion Capital LLC
White Lion Capital LLC, filed by
Kameel D. Farag, insider filing for AKTX
Kameel D. Farag, reporting
Samir Rashmikant Patel, insider filing for AKTX
Samir Rashmikant Patel, reporting
Kameel D. Farag, insider filing for AKTX
Kameel D. Farag, reporting
Ownership stake disclosure by MMCAP International Inc. SPC
MMCAP International Inc. SPC, filed by
Deutsche Bank Trust Co Americas/ ADR Group, filed by
James R Neal, insider filing for AKTX
James R Neal, reporting
Ownership stake disclosure by Raymond Prudo-Chlebosz (amended)
Raymond Prudo-Chlebosz, filed by
Ownership stake disclosure by Samir Rashmikant Patel (amended)
Samir Rashmikant Patel, filed by
Ownership stake disclosure by Hoyoung Huh (amended)
Hoyoung Huh, filed by